0000899243-19-019449.txt : 20190710 0000899243-19-019449.hdr.sgml : 20190710 20190710180307 ACCESSION NUMBER: 0000899243-19-019449 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190710 FILED AS OF DATE: 20190710 DATE AS OF CHANGE: 20190710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gardner Joseph H. CENTRAL INDEX KEY: 0001700816 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38560 FILM NUMBER: 19950129 MAIL ADDRESS: STREET 1: C/O AERPIO PHARMACEUTICALS, INC. STREET 2: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001422142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 BUSINESS PHONE: (513) 985-1920 MAIL ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP II DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-10 0 0001422142 Aerpio Pharmaceuticals, Inc. ARPO 0001700816 Gardner Joseph H. C/O AERPIO PHARMACEUTICALS, INC. 9987 CARVER ROAD, SUITE 420 CINCINNATI OH 45242 1 1 0 0 President Common Stock 2019-07-10 4 P 0 5000 0.8147 A 453019 D Common Stock 150000 I See Footnote The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.80 to $0.8217, inclusive. The reporting person undertakes to provide to Aerpio Pharmaceuticals, Inc., any security holder of Aerpio Pharmaceuticals, Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. These shares are owned by a Family Trust for the benefit of the reporting person's children. The reporting person's sibling is the trustee of the trust. The reporting person disclaims beneficial ownership of these shares. /s/ Amoli Pandya, Attorney in Fact 2019-07-10